-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2023.
- Aptose Biosciences Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$10.4M, a 1.52% increase year-over-year.
- Aptose Biosciences Inc. Net Cash Provided by (Used in) Operating Activities for the twelve months ending September 30, 2024 was -$37.2M, a 15.5% increase year-over-year.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$44.6M, a 38% decline from 2022.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$32.3M, a 25.4% increase from 2021.
- Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$43.3M, a 27.8% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)